Frontlight ResearchEarly access
Parkinson disease trials in Germany
27 of 45 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Where
- Dresden, Ebersberg
- Age
- 40 years to 85 years
- People
- 150 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT07514858 · EU 2025-524655-30-00 - Phase 2Not yet taking people in GermanyStudy to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Where
- Berlin, Dresden, Duesseldorf, Erlangen, Freiburg im Breisgau, Kassel, Luebeck, Muenster, Munich, Tuebingen
- Age
- 40 years to 85 years
- People
- 474 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Beelitz, Berlin, Bochum, Dresden, Duesseldorf, Erlangen, Freiburg im Breisgau, Hanover, Heidelberg, Homburg, Kassel, Muenster, Munich, Tuebingen, Wuerzburg
- Age
- 50 years to 85 years
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - Phase 2Taking peoplePrevent Cognitive Decline in GBA-associated Parkinson's Disease
- Where
- Dresden, Tübingen
- Age
- 35 years to 80 years
- People
- 120 worldwide
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07055087 · EU 2024-513496-40-00 - No phaseTaking peopleSTIMPulseControl Ancillary Speech Study
- Where
- Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte, Tübingen, Würzburg
- Age
- 18 years to 70 years
- People
- 60 worldwide
- Run by
- Steffen Paschen
See details and how to joinNCT06561919 - Phase 2/3Not yet taking people in GermanyA Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Where
- Bad Homburg, Berlin, Bochum, Bonn, Cologne, Dresden, Duesseldorf, Ebersberg, Erlangen, Gera, Goettingen, Hanover, Homburg, Kassel, Leipzig, Marburg, Munich, Regensburg, Ulm, Wuerzburg
- Age
- 40 years to 80 years
- People
- 550 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00 - No phaseTaking peopleBilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl
- Where
- Cologne, Dresden, Düsseldorf, Hamburg, Kassel, Kiel, Marburg, Mitte, Tübingen, Würzburg
- Age
- 18 years to 70 years
- People
- 60 worldwide
- Run by
- University of Kiel
See details and how to joinNCT06498349 - Phase 1Not yet taking people in GermanyA Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
- Where
- Dresden
- Age
- 18 years to 75 years
- People
- 106 worldwide
- Run by
- Mission Therapeutics
See details and how to joinNCT07630545 · EU 2024-517310-15-01 - Phase 1Taking peopleA Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Where
- Duesseldorf, Muenster
- Age
- 30 years to 80 years
- People
- 124 worldwide
- Run by
- Prevail Therapeutics
See details and how to joinNCT06565195 · EU 2024-513411-27-00 - No phaseTaking peoplePrevention-in-PD-Study
- Where
- Kiel
- Age
- 30 years to 85 years
- People
- 99
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT07297407 - Phase 1Not yet taking people in GermanyAssessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease
- Where
- Marburg
- Age
- 40 years to 75 years
- People
- 36 worldwide
- Run by
- Tridem Bioscience FlexCo
See details and how to joinNCT07840027 · EU 2024-519123-14-00 - Phase 2Not yet taking people in GermanyA Phase 2 study of VQ-101 in participants with Parkinson’s disease and GBA1 mutation
- Where
- Marburg
- Age
- 18 years and over
- People
- 16 worldwide
- Run by
- Vanqua Bio Inc.
See details and how to join2026-525848-15-00 - Phase 1/2Taking peopleSafety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
- Where
- Berlin, Dresden
- Age
- 50 years to 90 years
- People
- 75 worldwide
- Run by
- Integrative Research Laboratories AB
See details and how to joinNCT07461220 - No phaseTaking peopleCerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
- Where
- Hamburg
- Age
- 18 years and over
- People
- 10
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT06993571 - Early phase 1Taking peopleTest-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase
- Where
- Tübingen
- Age
- 50 years to 75 years
- People
- 9
- Run by
- MODAG GmbH
See details and how to joinNCT07640542 · EU 2023-506965-72-00 - Phase 4Taking peoplePatient- and care-related benefits of amyloid PET imaging (ENABLE)
- Where
- Berlin, Bonn, Cologne, Dresden, Erlangen, Essen, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Leipzig, Magdeburg, Mainz, Mannheim, Marburg, Munich, Rostock, Tuebingen, Ulm
- Age
- 18 years and over
- People
- 1,126
- Run by
- Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
See details and how to join2023-503705-10-00 - Phase 1Taking peopleA Study in Adults with Parkinson's Disease and a Lack of Interest or Motivation to Test How Different Doses of IRL757 Given for Multiple Days are Tolerated in the Body
- Where
- Berlin, Dresden, Muenster
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Integrative Research Laboratories Sweden AB
See details and how to join2025-523612-37-00 - Phase 3Taking peopleIntestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
- Where
- Berlin, Bottrop, Dresden, Marburg, Muenster, Potsdam, Rostock, Saarlouis, Tuebingen, Wolfach
- Age
- 18 years to 75 years
- People
- 150
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07151378 · EU 2025-521048-39-00 - No phaseTaking peopleBiomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease
- Where
- Münster
- Age
- 18 years and over
- People
- 30
- Run by
- University Hospital Muenster
See details and how to joinNCT07606547 - No phaseNot yet taking people in GermanyImpact of Diet on the Microbiome-Immune-Brain Axis in Parkinson's Disease
- Where
- Kiel
- Age
- 50 years to 80 years
- People
- 75
- Run by
- University of Kiel
See details and how to joinNCT06463769 - No phaseNot yet taking people in GermanyDual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI
- Where
- Tübingen
- Age
- 51 years to 80 years
- People
- 42
- Run by
- University Hospital Tuebingen
See details and how to joinNCT07411365 - No phaseTaking peopleSlowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
- Where
- Bonn
- Age
- 50 years to 80 years
- People
- 130
- Run by
- University Hospital, Bonn
See details and how to joinNCT07324330 - Phase 2Not yet taking people in GermanyEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
- Where
- Hessen
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Michael J. Fox Foundation for Parkinson's Research
See details and how to joinNCT07265596 - No phaseTaking peopleHome-based Gait and Balance Training in Patients With Movement Disorders
- Where
- Düsseldorf
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Forschungszentrum Juelich
See details and how to joinNCT06617884 - No phaseTaking peopleSteps Against the Burden of Parkinson's Disease - RCT Kiel
- Where
- Kiel
- People
- 42
- Run by
- University of Kiel
See details and how to joinNCT07058285